Precision neuropsychiatry:
patient-centric drug design
patient-centric drug design
At Reconnect Labs, we utilize precision neuropsychiatry to design safer, more cost effective drugs that can rapidly address symptoms and the underlying pathology of mental health conditions in target patient populations.
Our approach
Precision therapeutics
Leveraging cutting-edge pharmaceutical technologies and deep expertise in psychiatry to design scalable, rapid-acting formulations for superior efficacy, high tolerability, low side-effect profiles, and cost-effective clinical use.
Predictive diagnostics
Developing proprietary, low-cost and non-invasive digital psychiatry tools – psychometrics and autonomic biomarkers – to reduce placebo in clinical trials and to scalably predict patient response and improve outcomes.
Novel molecular targets with multimodal benefits
Advancing compounds with targeted neurobiological and psychological mechanisms of action to rapidly address symptoms and core disease mechanisms.
We precision reformulate molecules with in-human evidence for psychiatric disorders with no or poor standards of care….
…to have targeted, regenerative mechanisms of action and highly differentiated profiles for commercial scalability.
And run gold standard, expedited clinical trials in our affiliated Swiss research labs….
…to deliver first-in-class drugs with highly superior efficacy, economic and patient safety profiles.
